35274367|t|Clinical value of serum JKAP in acute ischemic stroke patients.
35274367|a|BACKGROUND: Jun N-terminal kinase pathway-associated phosphatase (JKAP) regulates neuronal function, T helper (Th) 1/2/17 cell differentiation, and inflammatory process, but its clinical role in acute ischemic stroke (AIS) patients remains unclear. Hence, this study intended to evaluate JKAP level and its relationship with disease severity, Th1, 2, 17 secreted cytokines, adhesion molecules, and prognosis of AIS patients. METHODS: Serum JKAP of 122 AIS patients and 50 controls was detected by ELISA. For AIS patients only, Th1, 2, 17 secreted cytokines IFN-gamma, IL-4, IL-17; TNF-alpha, ICAM-1, and VCAM-1 were also detected by ELISA. RESULTS: JKAP was decreased in AIS patients compared with controls (46.350 (interquartile range (IQR): 34.250-59.875) pg/ml vs. 84.500 (IQR: 63.175-113.275) pg/ml, p < 0.001), which could distinguish AIS patients from controls (area under curve (AUC): 0.810, 95% confidence interval (CI): 0.732-0.888). In AIS patients, JKAP negatively linked with the National Institutes of Health Stroke Scale (NIHSS) score (rs  = -0.342, p < 0.001); besides, it was positively related to IL-4 (rs  = 0.213, p = 0.018) and negatively associated with IL-17 (rs  = -0.270, p = 0.003) but not related to IFN-gamma (rs  = -0.146, p = 0.109). Furthermore, elevated JKAP associated with declined TNF-alpha (rs  = -0.219, p = 0.015) and ICAM-1 (rs  = -0.235, p = 0.009) but not related to VCAM-1 (rs  = -0.156, p = 0.085). Besides, declined JKAP was linked with 2-year recurrence (p = 0.027) and 3-year recurrence (p = 0.010) in AIS patients; while JKAP was not related to 1-year recurrence or death risk (both p > 0.050). CONCLUSION: JKAP may sever as a candidate prognostic biomarker in AIS patients, indicating its potency for AIS management.
35274367	24	28	JKAP	Gene	56940
35274367	32	53	acute ischemic stroke	Disease	MESH:D000083242
35274367	54	62	patients	Species	9606
35274367	76	128	Jun N-terminal kinase pathway-associated phosphatase	Gene	56940
35274367	130	134	JKAP	Gene	56940
35274367	212	224	inflammatory	Disease	MESH:D007249
35274367	259	280	acute ischemic stroke	Disease	MESH:D000083242
35274367	282	285	AIS	Disease	MESH:D000083242
35274367	287	295	patients	Species	9606
35274367	352	356	JKAP	Gene	56940
35274367	475	478	AIS	Disease	MESH:D000083242
35274367	479	487	patients	Species	9606
35274367	504	508	JKAP	Gene	56940
35274367	516	519	AIS	Disease	MESH:D000083242
35274367	520	528	patients	Species	9606
35274367	572	575	AIS	Disease	MESH:D000083242
35274367	576	584	patients	Species	9606
35274367	621	630	IFN-gamma	Gene	3458
35274367	632	636	IL-4	Gene	3565
35274367	638	643	IL-17	Gene	3605
35274367	645	654	TNF-alpha	Gene	7124
35274367	656	662	ICAM-1	Gene	3383
35274367	668	674	VCAM-1	Gene	7412
35274367	713	717	JKAP	Gene	56940
35274367	735	738	AIS	Disease	MESH:D000083242
35274367	739	747	patients	Species	9606
35274367	904	907	AIS	Disease	MESH:D000083242
35274367	908	916	patients	Species	9606
35274367	1010	1013	AIS	Disease	MESH:D000083242
35274367	1014	1022	patients	Species	9606
35274367	1024	1028	JKAP	Gene	56940
35274367	1086	1092	Stroke	Disease	MESH:D020521
35274367	1178	1182	IL-4	Gene	3565
35274367	1239	1244	IL-17	Gene	3605
35274367	1290	1299	IFN-gamma	Gene	3458
35274367	1349	1353	JKAP	Gene	56940
35274367	1379	1388	TNF-alpha	Gene	7124
35274367	1419	1425	ICAM-1	Gene	3383
35274367	1471	1477	VCAM-1	Gene	7412
35274367	1523	1527	JKAP	Gene	56940
35274367	1611	1614	AIS	Disease	MESH:D000083242
35274367	1615	1623	patients	Species	9606
35274367	1631	1635	JKAP	Gene	56940
35274367	1676	1681	death	Disease	MESH:D003643
35274367	1717	1721	JKAP	Gene	56940
35274367	1771	1774	AIS	Disease	MESH:D000083242
35274367	1775	1783	patients	Species	9606
35274367	1812	1815	AIS	Disease	MESH:D000083242
35274367	Association	3605	56940
35274367	Association	MESH:D000083242	56940
35274367	Association	MESH:D007249	56940
35274367	Positive_Correlation	3565	56940
35274367	Association	56940	7124
35274367	Association	MESH:D003643	56940

